A Mix of These Specific Foods Could Help You Avoid Chronic Disease
For the good of your health, you might want to favor a wider mix of flavonoids in your diet. These natural plant compounds – found in teas, berries, apples, and dark chocolate – have been linked to longer life and a lower risk of disease, new evidence shows.
In particular, it was the broader range of flavonoids that made a difference in this research, not just the higher quantity of them. Flavonoids have previously been connected to anti-inflammatory effects in the body, and reductions in the risk of weight gain, cardiovascular disease, and vision loss.
An international team of researchers analyzed data on 124,805 adults in the UK, aged 40 or over. They looked for links between the self-reported diets of the participants and their health, over several years.
"We have known for some time that higher intakes of dietary flavonoids, powerful bioactives naturally present in many foods and drinks, can reduce the risk of developing heart disease, type 2 diabetes, and neurological conditions like Parkinson's," says nutritional scientist Aedín Cassidy from Queen's University Belfast in Northern Ireland.
"This study is significant as the results indicate that consuming a higher quantity and wider diversity has the potential to lead to a greater reduction in ill health than just a single source."
Black and green teas were the most common provider of flavonoids in the study, drunk by two-thirds of the participants. Other sources included apples, red wine, grapes, berries, dark chocolate, oranges, satsumas, and orange juice.
The statistics showed that participants whose diets had the widest diversity of flavonoid foods had a lower risk of all-cause mortality, and of numerous health complications. While the data doesn't prove direct cause and effect, the strong suggestion is that mixing your flavonoids is good for you.
"Flavonoid intakes of around 500 milligram a day were associated with a 16 percent lower risk of all-cause mortality, as well as around a 10 percent lower risk of cardiovascular disease, type 2 diabetes, and respiratory disease," says nutrition scientist Benjamin Parmenter from Edith Cowan University in Australia.
"That's roughly the amount of flavonoids that you would consume in two cups of tea."
Even when consuming the same total amount of flavonoids, those who consumed the widest diversity had even lower risk of these diseases, the researchers found.
The top fifth of the participants in terms of diversity of flavonoid intake saw reductions of around 6-20 percent in the risk of conditions like type 2 diabetes, cancer, and neurodegenerative disease, compared to the bottom fifth.
With that in mind, the researchers are recommending a mix of flavonoid-rich food and drink, every day. If you want to set yourself a challenge, the top flavonoid consumers in this study were snacking on 19 different types per day.
"Eating fruits and vegetables in a variety of colors, including those rich in flavonoids, means you're more likely to get the vitamins and nutrients you need to sustain a healthier lifestyle," says nutrition scientist Tilman Kuhn from the Medical University of Vienna in Austria.
The research was published in Nature Food.
One Fitness Accessory Makes You Up to 7 Times More Likely to Stay Active
Study Reveals How Much Exercise You Need Each Week to Control Blood Pressure
A Toxicologist Reveals The Surprising Truth About Black Mold
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
32 minutes ago
- Bloomberg
UK Names Blaise Metreweli as First Woman to Head MI6 Spy Service
The UK appointed the first woman to lead its secret intelligence service MI6 as Prime Minster Keir Starmer warned of the increasing threats Britain faces from its adversaries. Blaise Metreweli, 47, will succeed Richard Moore as MI6 chief in the autumn, the premier's office announced Sunday. She is currently director general of technology and innovation - a role known as 'Q' that was made globally famous in the James Bond movie franchise.
Yahoo
an hour ago
- Yahoo
Statement from the Alzheimer's Drug Discovery Foundation on the Passing of ADDF Co-Founder and Co-Chairman Leonard A. Lauder
The Lauder Family's Vision and Catalytic Funding Through the ADDF Helped Seed and Transform the Alzheimer's Research Landscape NEW YORK, June 15, 2025 /PRNewswire/ -- It is with deep sorrow and profound admiration that the Alzheimer's Drug Discovery Foundation (ADDF) shares the passing of Co-Founder and Chairman, Leonard A. Lauder. A visionary philanthropist, cosmetics industry icon, and steadfast champion in the fight against Alzheimer's disease, Lauder's legacy is woven into the very fabric of the ADDF and the progress it has driven toward understanding, treating, and ultimately curing Alzheimer's. "Leonard Lauder was a once-in-a-generation visionary whose leadership, along with his brother Ronald, reshaped the Alzheimer's research landscape," said Dr. Howard Fillit, Co-Founder and Chief Science Officer of the ADDF. "From the very beginning, Leonard understood that Alzheimer's does not just impact the patient, it affects entire families. The Lauder family recognized the emotional, financial, and societal toll of this disease, and built the ADDF to accelerate the discovery and development of treatments that could change the trajectory for patients and their loved ones. Leonard's vision, generosity, and humanity spanned across his business acumen to his philanthropic endeavors, touching countless lives, and his legacy will endure in every breakthrough we help bring forward." Lauder and his brother, Ronald S. Lauder, co-founded the ADDF in 1998 with Dr. Fillit in honor of their mother, Estee Lauder's, battle with Alzheimer's. At a time when Alzheimer's research funding was sparse and interest from the private sector limited, the Lauder family recognized the urgent need for treatments and created a bold new venture philanthropy model to achieve this mission, combining the rigor of scientific research with the agility and entrepreneurialism of venture capital. For over more than 27 years, the Lauders' leadership helped shape the ADDF into the world's leading philanthropic funder of drug discovery and development research. Under the Lauders' guidance, the ADDF has: Invested more than $370 million into over 765 drug discovery programs across 21 countries Catalyzed more than $3 billion in follow-on funding from pharmaceutical companies, venture capital firms, and government agencies, helping to de-risk early-stage science and attract broader investment into Alzheimer's research Played a pivotal role in the development of the first biomarkers for Alzheimer's by providing early seed funding for Amyvid, the first FDA-approved PET scan for Alzheimer's; PrecivityAD, the first Alzheimer's blood test to market; and Lumipulse, the first Alzheimer's blood test to receive FDA approval Established the Diagnostics Accelerator (DxA) in partnership with Bill Gates and other visionary philanthropists to advance affordable, accessible diagnostic tools, a critical step toward earlier detection and intervention Advanced a diverse pipeline of treatments by pioneering the biology of aging approach, now central to the field, with over 70% of drugs targeting disease pathways such as inflammation, neuroprotection, vascular health, and synaptic function, paving the way for Alzheimer's to be treated with combination therapy and precision medicine, as in cancer Brought forward a precision prevention approach, combining lifestyle interventions and therapeutics to slow the progression or prevent the onset of Alzheimer's altogether Through all these achievements, Lauder and his family remained deeply committed to the ADDF's mission. "Leonard's impact on the ADDF, and on the field of Alzheimer's research more broadly, is immeasurable," said Mark Roithmayr, Chief Executive Officer of the ADDF. "He brought a sense of urgency to this work that pushed us all to do more and move faster. He believed that patients and families deserve better and he committed himself fully to building a world in which effective treatments are not only possible, but inevitable. His leadership, his generosity, and his humanity will continue to guide the ADDF's mission every day." Lauder's impact extended across business, culture, and philanthropy. Yet for those who worked alongside him at the ADDF, he will be remembered most for his compassion, clarity of purpose, and unwavering belief in progress. He understood that Alzheimer's is a deeply human and societal challenge, one affecting memory, identity, and dignity. The ADDF honors Lauder's legacy by reaffirming our commitment to conquer Alzheimer's for the millions of patients and families living with this devastating disease. About The Alzheimer's Drug Discovery Foundation (ADDF)Founded in 1998 by Leonard A. and Ronald S. Lauder, the Alzheimer's Drug Discovery Foundation is dedicated to rapidly accelerating the discovery of drugs to prevent, treat and cure Alzheimer's disease. The ADDF is the only public charity solely focused on funding the development of drugs for Alzheimer's, employing a venture philanthropy model to support research in academia and the biotech industry. The ADDF's leadership and contributions to the field have played a pivotal role in bringing the first Alzheimer's PET scan (Amyvid®) and blood test (PrecivityAD®) to market, as well as fueling the current robust and diverse drug pipeline. Through the generosity of its donors, the ADDF has awarded more than $370 million to fund 765 Alzheimer's drug discovery programs, biomarker programs and clinical trials in 21 countries. To learn more, please visit: View original content to download multimedia: SOURCE Alzheimer's Drug Discovery Foundation
Yahoo
an hour ago
- Yahoo
Doing This 1-Minute Move Every Day Can Undo Hours of Sitting, Trainer Says
Doing This 1-Minute Move Every Day Can Undo Hours of Sitting, Trainer Says originally appeared on Men's Fitness. Your hips, shoulders, and back are begging you to stretch, especially if you sit all day. Jeff Cavaliere, C.S.C.S., is known for sharing practical routines that help athletes and everyday people move and feel better. One of his go-to recommendations is a simple full-body stretch—kneeling door splats—that you can do daily to maintain mobility and counteract the effects of sitting too much. According to the CDC, an estimated 20.9 percent of U.S. adults—over 51 million people—experienced chronic pain in 2021. Around 6.9 percent reported high-impact chronic pain that significantly restricted their daily activities. Stretching may not necessarily be the solution to chronic pain. But, as Gary Liguori, senior editor of the American College of Sports Medicine's 2021 exercise guidelines, shared with the American Heart Association, never stretching can lead to decreased range of motion over perform the full-body stretch, start in a kneeling lunge position. Place your hands at chest level on either side of a doorway, then lean forward through the doorway. Keep your elbows pointed down as you hold the position. This externally rotates your shoulders while also targeting your chest and hips. "You're trying to pinch your shoulder blades together. Now you've got more hip flexion, so you're getting deeper into your hips," Cavaliere says. You'll feel it in your shoulders, chest, and especially your hip flexors—particularly if you're tight in those areas. Hold the stretch for 30 seconds on one leg, then switch to the other. Perform the stretch daily for best This 1-Minute Move Every Day Can Undo Hours of Sitting, Trainer Says first appeared on Men's Fitness on Jun 13, 2025 This story was originally reported by Men's Fitness on Jun 13, 2025, where it first appeared.
